Sleep apnea and the risk of chronic kidney disease: A nationwide population-based cohort study

Sleep

Volumn 38, Issue 2, 2015, Pages 213-221A

  Lee, Yi Che ^a,c   Hung, Shih Yuan ^a   Wang, Hao Kuang ^a,c   Lin, Chi Wei ^a   Wang, Hsi Hao ^a   Chen, Shih Wei ^b   Chang, Min Yu ^a   Ho, Li Chun ^a,c   Chen, Yi Ting ^a   Liou, Hung Hsiang ^d   Tsai, Tsuen Chiuan ^a   Tseng, Shih Hann ^f   Wang, Wei Ming ^e   Lin, Sheng Hsiang ^c   Chiou, Yuan Yow ^c,e  

^a I SHOU UNIVERSITY   (Taiwan)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^d Hsin Jen Hospital   (Taiwan)

^e NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^f Hong En Clinic   (Taiwan)

Author keywords

Chronic kidney disease; Cohort study; End stage renal disease; National Health Insurance; Sleep apnea

Indexed keywords

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; END STAGE RENAL DISEASE; FEMALE; HUMAN; INCIDENCE; KIDNEY FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SLEEP DISORDERED BREATHING; COMPLICATION; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; PATHOPHYSIOLOGY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; SLEEP APNEA SYNDROMES; TAIWAN;

ADULT; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK FACTORS; SLEEP APNEA SYNDROMES; TAIWAN;

EID: 84922025518     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4400     Document Type: Article

References (85)

1. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Cric Care Med 2002;165:1217-39.
2. Dursunoglu N, Dursunoglu D. [Obstructive sleep apnea syndrome, endothelial dysfunction and coronary atherosclerosis]. Tuberkuloz ve toraks 2005;53:299-306.
3. Arnaud C, Dematteis M, Pepin JL, Baguet JP, Levy P. Obstructive sleep apnea, immuno-inflammation, and atherosclerosis. Semin Immunopathol 2009;31:113-25.
4. Stinghen AE, Goncalves SM, Martines EG, et al. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease. Nephron Clin Pract 2009;111:c117-26.
5. Jelic S, Lederer DJ, Adams T, et al. Vascular inflammation in obesity and sleep apnea. Circulation 2010;121:1014-21.
6. Lurie A. Hemodynamic and autonomic changes in adults with obstructive sleep apnea. Adv Cardiol 2011;46:171-95.
7. Caballo C, Palomo M, Cases A, et al. NFkappaB in the development of endothelial activation and damage in uremia: an in vitro approach. PLoS One 2012;7:e43374.
8. Ramirez JM, Garcia AJ, 3rd, Anderson TM, et al. Central and peripheral factors contributing to obstructive sleep apneas. Respir Physiol Neurobiol 2013;189:344-53.
9. Young T, Evans L, Finn L, Palta M. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 1997;20:705-6.
10. Selim B, Won C, Yaggi HK. Cardiovascular consequences of sleep apnea. Clin Chest Med 2010;31:203-20.
11. Greenberg-Dotan S, Reuveni H, Tal A, et al. Increased prevalence of obstructive lung disease in patients with obstructive sleep apnea. Sleep Breath 2014;18:69-75.
12. Kalamas AG, Niemann CU. Patients with chronic kidney disease. Med Clin North Am2013;97:1109-22.
13. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005;16:180-8.
14. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan. Lancet 2008;371:2173-82.
15. Iseki K, Tohyama K, Matsumoto T, Nakamura H. High Prevalence of chronic kidney disease among patients with sleep related breathing disorder (SRBD). Hypertens Res 2008;31:249-55.
16. Sim JJ, Rasgon SA, Kujubu DA, et al. Sleep apnea in early and advanced chronic kidney disease: Kaiser Permanente Southern California cohort. Chest 2009;135:710-6.
17. Fleischmann G, Fillafer G, Matterer H, Skrabal F, Kotanko P. Prevalence of chronic kidney disease in patients with suspected sleep apnoea. Nephrol Dial Transplant 2010;25:181-6.
18. Chou YT, Lee PH, Yang CT, et al. Obstructive sleep apnea: a standalone risk factor for chronic kidney disease. Nephrol Dial Transplant 2011;26:2244-50.
19. Kanbay A, Buyukoglan H, Ozdogan N, et al. Obstructive sleep apnea syndrome is related to the progression of chronic kidney disease. Int Urol Nephrol 2012;44:535-9.
20. Krieger J, Imbs JL, Schmidt M, Kurtz D. Renal function in patients with obstructive sleep apnea. Effects of nasal continuous positive airway pressure. Arch Intern Med 1988;148:1337-40.
21. Kinebuchi S, Kazama JJ, Satoh M, et al. Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome. Clin Sci (Lond) 2004;107:317-22.
22. Markou N, Kanakaki M, Myrianthefs P, et al. Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 2006;184:43-9.
23. Faulx MD, Storfer-Isser A, Kirchner HL, Jenny NS, Tracy RP, Redline S. Obstructive sleep apnea is associated with increased urinary albumin excretion. Sleep 2007;30:923-9.
24. Canales MT, Lui LY, Taylor BC, et al. Renal function and sleep-disordered breathing in older men. Nephrol Dial Transplant 2008;23:3908-14.
25. Markou N, Kanakaki M. Sleep-disordered breathing and reductions in renal function: are they associated in the elderly? Sleep Med 2008;9:598-600.
26. Tsioufis C, Thomopoulos C, Dimitriadis K, et al. Association of obstructive sleep apnea with urinary albumin excretion in essential hypertension: a cross-sectional study. Am J Kidney Dis 2008;52:285-93.
27. Ursavas A, Karadag M, Gullulu M, et al. Low-grade urinary albumin excretion in normotensive/non-diabetic obstructive sleep apnea patients. Sleep Breath 2008;12:217-22.
28. Canales MT, Paudel ML, Taylor BC, et al. Sleep-disordered breathing and urinary albumin excretion in older men. Sleep Breath 2011;15:137-44.
29. Kato K, Takata Y, Usui Y, et al. Severe obstructive sleep apnea increases cystatin C in clinically latent renal dysfunction. Respir Med 2011;105:643-9.
30. Roumelioti ME, Buysse DJ, Sanders MH, Strollo P, Newman AB, Unruh ML. Sleep-disordered breathing and excessive daytime sleepiness in chronic kidney disease and hemodialysis. Clin J Am Soc Nephrol 2011;6:986-94.
31. Sakaguchi Y, Shoji T, Kawabata H, et al. High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol 2011;6:995-1000.
32. Nicholl DD, Ahmed SB, Loewen AH, et al. Declining kidney function increases the prevalence of sleep apnea and nocturnal hypoxia. Chest 2012;141:1422-30.
33. Chien IC, Chou YJ, Lin CH, Bih SH, Chou P. Prevalence of psychiatric disorders among National Health Insurance enrollees in Taiwan. Psychiatr Serv 2004;55:691-7.
34. National health insurance research database. [updated 2003; cited 2013 Aug]. Available from: http://nhird.nhri.org.tw/.
35. Longitudinal Health Insurance Database 2000. [cited 2013 Aug]. Available from: http://nhird.nhri.org.tw/en/Data-Subsets.html#S3.
36. Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology 2012;56:698-705.
37. Hsu YC, Lin JT, Ho HJ, et al. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology 2014;59:1293-302.
38. Tiao MM, Tsai SS, Kuo HW, Chen CL, Yang CY. Epidemiological features of biliary atresia in Taiwan, a national study 1996-2003. J Gastroenterol Hepatol 2008;23:62-6.
39. Chiang CW, Chen CY, Chiu HF, Wu HL, Yang CY. Trends in the use of antihypertensive drugs by outpatients with diabetes in Taiwan, 1997-2003. Pharmacoepidemiol Drug Saf 2007;16:412-21.
40. Kuo HW, Tsai SS, Tiao MM, Yang CY. Epidemiological features of CKD in Taiwan. Am J Kidney Dis 2007;49:46-55.
41. Kang JH, Lin HC. Obstructive sleep apnea and the risk of autoimmune diseases: a longitudinal population-based study. Sleep Med 2012;13:583-8.
42. de Graaf MA, Jager KJ, Zoccali C, Dekker FW. Matching, an appealing method to avoid confounding? Nephron Clin Pract 2011;118:c315-8.
43. Valery PC, Coory M, Stirling J, Green AC. Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. Lancet 2006;367:1842-8.
44. Costanza MC. Matching. Preventive Med 1995;24:425-33.
45. Wang HK, Lin SH, Sung PS, et al. Population based study on patients with traumatic brain injury suggests increased risk of dementia. J Neurol Neurosurg Psychiatry 2012;83:1080-5.
46. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008.
47. Liu CY, Hung YT, Chuang YL, et al. Incorporating development stratification of Taiwan townships into sampling design of large scale health interview survey. J Health Manag 2006;14:1-22.
48. Kronbichler A, Mayer G. Renal involvement in autoimmune connective tissue diseases. BMC Med 2013;11:95.
49. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-100.
50. Fathallah-Shaykh SA, Cramer MT. Uric acid and the kidney. Pediatr Nephrol 2014;29:999-1008.
51. Keddis MT, Rule AD. Nephrolithiasis and loss of kidney function. Curr Opin Nephrol Hypertens 2013;22:390-6.
52. Centers for Disease Control and Prevention (CDC). Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004. MMWR Morb Mortal Wkly Rept 2007;56:161-5.
53. Pipili C, Ilonidis G, Cholongitas E. Hepatitis C virus and kidney: a strong association with different clinical aspects. Liver Int 2011;31:1071-80.
54. Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P. Hepatitis C virus infection, mixed cryoglobulinemia, and kidney disease. Am J Kidney Dis 2013;61:623-37.
55. Ishii Y. [Smoking and respiratory diseases]. Nihon rinsho. Jpn J Clin Med 2013;71:416-20.
56. Chen YC, Su YC, Lee CC, Huang YS, Hwang SJ. Chronic kidney disease itself is a causal risk factor for stroke beyond traditional cardiovascular risk factors: a nationwide cohort study in Taiwan. PLoS One 2012;7:e36332.
57. Kuo CC, Kuo HW, Lee IM, Lee CT, Yang CY. The risk of upper gastrointestinal bleeding in patients treated with hemodialysis: a population-based cohort study. BMC Nephrol 2013;14:15.
58. Kuo CC, Lee CT, Lee IM, Ho SC, Yang CY. Risk of herpes zoster in patients treated with long-term hemodialysis: a matched cohort study. Am J Kidney Dis 2012;59:428-33.
59. Chen YC, Chiou WY, Hung SK, Su YC, Hwang SJ. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan. BMC Nephrol 2013;14:187.
60. Catastrophic Illness Patients [updated 2011; cited 2013 Aug]. Available from: http://www.nhi.gov.tw/English/webdata/webdata.aspx?menu=11&menu-id=596&WD-ID=596&webdata-id=3180.
61. American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic and coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine, 2005.
62. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
63. Kleinbaum DG, Klein M. Survival analysis: a self-learning text. 3rd ed. New York: Springer, 2012.
64. Fine JP GR. A proportional hazards model for the subdistribution of a competing risk. J Am Statistical Assoc 1999;94:496-509.
65. Subdistribution Analysis of Competing Risks. [cited 2014 May]. Available from: http://cran.r-project.org/web/packages/cmprsk/index.html.
66. Lin DY, Psaty BM, Kronmal RA. Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 1998;54:948-63.
67. Kanagy NL, Walker BR, Nelin LD. Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 2001;37:511-5.
68. Nacher M, Serrano-Mollar A, Farre R, Panes J, Segui J, Montserrat JM. Recurrent obstructive apneas trigger early systemic inflammation in a rat model of sleep apnea. Respir Physiol Neurobiol 2007;155:93-6.
69. Dyugovskaya L, Lavie P, Lavie L. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann N Y Acad Sci 2005;1051:340-50.
70. Dyugovskaya L, Lavie P, Hirsh M, Lavie L. Activated CD8+ T-lymphocytes in obstructive sleep apnoea. Eur Respir J 2005;25:820-8.
71. Dyugovskaya L, Lavie P, Lavie L. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 2003;168:242-9.
72. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934-9.
73. Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. Pflugers Arch 2005;450:363-71.
74. Ryan S, Taylor CT, McNicholas WT. Predictors of elevated nuclear factor-kappaB-dependent genes in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2006;174:824-30.
75. Lavie L, Lavie P. Molecular mechanisms of cardiovascular disease in OSAHS: the oxidative stress link. Eur Respir J 2009;33:1467-84.
76. Schulz R, Hummel C, Heinemann S, Seeger W, Grimminger F. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med 2002;165:67-70.
77. Chiu HF, Huang YW, Chang CC, Yang CY. Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf 2010;19:1131-6.
78. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009;137:1641-8 e1-2.
79. Stenvinkel P, Ikizler TA, Mallamaci F, Zoccali C. Obesity and nephrology: results of a knowledge and practice pattern survey. Nephrol Dial Transplant 2013;28 Suppl 4:iv99-104.
80. Nderitu P, Doos L, Jones PW, Davies SJ, Kadam UT. Non-steroidal antiinflammatory drugs and chronic kidney disease progression: a systematic review. Fam Pract 2013;30:247-55.
81. Noborisaka Y. Smoking and chronic kidney disease in healthy populations. Nephrourol Mon 2013;5:655-67.
82. Tausche AK, Jansen TL, Schroder HE, Bornstein SR, Aringer M, Muller-Ladner U. Gout-current diagnosis and treatment. Deutsches Arzteblatt Int 2009;106:549-55.
83. Ramiro S, Radner H, van der Heijde DM, Buchbinder R, Aletaha D, Landewe RB. Combination therapy for pain management in inflammatory arthritis: a Cochrane systematic review. J Rheumatol Suppl 2012;90:47-55.
84. Plantinga LC. Socio-economic impact in CKD. Nephrol Ther 2013;9:1-7.
85. Vart P, Gansevoort RT, Coresh J, Reijneveld SA, Bultmann U. Socioeconomic Measures and CKD in the United States and The Netherlands. Clin J Am Soc Nephrol 2013;8:1685-93.